Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Health Professions Clinical Education Update: Recommendations and Strategies 2026. A Report of the ASAHP Clinical Education Committee.
Journal: Journal of allied health
Published: July 31, 2025
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: March 20, 2023
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease.
Journal: Journal of clinical pharmacology
Published: December 27, 2022
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.
Journal: Journal of Crohn's & colitis
Published: May 26, 2021
A long-term, open-label study of valbenazine for tardive dyskinesia.
Journal: CNS spectrums
Published: May 19, 2020
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 21, 2018
Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: July 24, 2018
A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 18, 2018
Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study.
Journal: The Journal of clinical psychiatry
Published: April 03, 2018
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.
Journal: Drug safety
Published: December 09, 2017
Last Updated: 09/26/2026